Work

Abstract PS5-09-02: Phase 2 study of adjuvant liposomal doxorubicin and carboplatin for early-stage triple negative breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-09-02

Authors: M. George, C. Omene, A. Litvak, G. Raptis, A. Cruz, K. Toomey, S. Kumar, N. Ohri, L. Potdevin, K. Harper, E. L. Gramiccioni, B. Haffty, H. S. Sloane, D. Toppmeyer

Institutions: Rutgers Cancer Institute, Saint Barnabas Medical Center, Jersey City Medical Center, C3J Therapeutics (United States)

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129473438

Cites:

Cited by:

Related to: